Outcomes of Large Vessel Occlusion Stroke in Patients Aged ≥90 Years.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 2 3 2021
medline: 4 1 2022
entrez: 1 3 2021
Statut: ppublish

Résumé

Outcomes in patients ≥90 years of age with stroke due to large vessel occlusion were compared between endovascular therapy (EVT) and medical management. Of 2420 acute ischemic stroke patients with large vessel occlusion in a prospective, multicenter, nationwide registry in Japan, patients aged ≥90 years with occlusion of the internal carotid artery or M1 segment of the middle cerebral artery were included. The primary effectiveness outcome was a favorable outcome at 3 months, defined as achieving a modified Rankin Scale score of 0 to 2 or return to at least the prestroke modified Rankin Scale score at 3 months. Safety outcomes included symptomatic intracranial hemorrhage within 72 hours after onset. Intergroup biases were adjusted by multivariable adjustment with inverse probability of treatment weighting. A total of 150 patients (median age, 92 [interquartile range, 90-94] years; median prestroke modified Rankin Scale score, 2 [interquartile range, 0-4]) were analyzed. EVT was performed in 49 patients (32.7%; mechanical thrombectomy, n=43). The EVT group showed shorter time from onset to hospital arrival ( Patients who underwent EVT showed better functional outcomes than those with medical management without increased symptomatic intracranial hemorrhages. Given proper patient selection, withholding EVT solely on the basis of the age of patients may not offer the best chance of good outcome. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02419794.

Sections du résumé

BACKGROUND AND PURPOSE
Outcomes in patients ≥90 years of age with stroke due to large vessel occlusion were compared between endovascular therapy (EVT) and medical management.
METHODS
Of 2420 acute ischemic stroke patients with large vessel occlusion in a prospective, multicenter, nationwide registry in Japan, patients aged ≥90 years with occlusion of the internal carotid artery or M1 segment of the middle cerebral artery were included. The primary effectiveness outcome was a favorable outcome at 3 months, defined as achieving a modified Rankin Scale score of 0 to 2 or return to at least the prestroke modified Rankin Scale score at 3 months. Safety outcomes included symptomatic intracranial hemorrhage within 72 hours after onset. Intergroup biases were adjusted by multivariable adjustment with inverse probability of treatment weighting.
RESULTS
A total of 150 patients (median age, 92 [interquartile range, 90-94] years; median prestroke modified Rankin Scale score, 2 [interquartile range, 0-4]) were analyzed. EVT was performed in 49 patients (32.7%; mechanical thrombectomy, n=43). The EVT group showed shorter time from onset to hospital arrival (
CONCLUSIONS
Patients who underwent EVT showed better functional outcomes than those with medical management without increased symptomatic intracranial hemorrhages. Given proper patient selection, withholding EVT solely on the basis of the age of patients may not offer the best chance of good outcome. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02419794.

Identifiants

pubmed: 33641385
doi: 10.1161/STROKEAHA.120.031386
doi:

Substances chimiques

Fibrinolytic Agents 0
Tissue Plasminogen Activator EC 3.4.21.68

Banques de données

ClinicalTrials.gov
['NCT02419794']

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1561-1569

Commentaires et corrections

Type : ErratumIn

Auteurs

Kyohei Fujita (K)

Department of Cerebrovascular Medicine (K.F., K. Toyoda), National Cerebral and Cardiovascular Center, Suita, Japan.

Kanta Tanaka (K)

Division of Stroke Care Unit (K. Tanaka, H.Y.), National Cerebral and Cardiovascular Center, Suita, Japan.

Hiroshi Yamagami (H)

Division of Stroke Care Unit (K. Tanaka, H.Y.), National Cerebral and Cardiovascular Center, Suita, Japan.
Department of Neurology (H.Y., T.Y.), National Cerebral and Cardiovascular Center, Suita, Japan.

Takeshi Yoshimoto (T)

Department of Neurology (H.Y., T.Y.), National Cerebral and Cardiovascular Center, Suita, Japan.

Kazutaka Uchida (K)

Department of Neurosurgery (K.U., S.Y.), Hyogo College of Medicine, Nishinomiya, Japan.
Department of Clinical Epidemiology (K.U., T.M.), Hyogo College of Medicine, Nishinomiya, Japan.

Takeshi Morimoto (T)

Department of Clinical Epidemiology (K.U., T.M.), Hyogo College of Medicine, Nishinomiya, Japan.

Hirotoshi Imamura (H)

Department of Neurosurgery (H.I., N.S.), Kobe City Medical Center General Hospital, Japan.

Nobuyuki Sakai (N)

Department of Neurosurgery (H.I., N.S.), Kobe City Medical Center General Hospital, Japan.

Nobuyuki Ohara (N)

Department of Neurology (N.O.), Kobe City Medical Center General Hospital, Japan.

Yasushi Matsumoto (Y)

Department of Neuroendovascular Therapy, Kohnan Hospital, Miyagi, Japan (Y.M.).

Masataka Takeuchi (M)

Department of Neurosurgery, Seishou Hospital, Odawara, Japan (M.T.).

Keigo Shigeta (K)

Department of Neurosurgery, Disaster Medical Center, National Hospital Organization, Tachikawa, Japan (K.S.).

Kazunori Toyoda (K)

Department of Cerebrovascular Medicine (K.F., K. Toyoda), National Cerebral and Cardiovascular Center, Suita, Japan.

Shinichi Yoshimura (S)

Department of Neurosurgery (K.U., S.Y.), Hyogo College of Medicine, Nishinomiya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH